Aimed at taking collaborations and partnerships to the next level, the Organisation of Pharmaceutical Producers of India (OPPI) will organise the 9th edition of its Annual Summit – Healthcare Accelerated on December 17 and 18 through the virtual platform.
The theme of this year’s summit is India’s Healthcare Transformational Journey. Union Minister for Chemicals and Fertilizers D V Sadananda Gowda, Minister of State for Shipping, Chemicals and Fertilizers Mansukh Mandaviya and Chief Economic advisor of India Dr Krishnamurthy Subramanian will speak at the summit.
OPPI President Sharad Tyagi will talk on ‘Reimagining India’s Healthcare in the next decade,’ followed by an address by OPPI Director General, KG Ananthakrishanan on ‘Refreshing research’.
The summit will confer the Lifetime Recognition Award to founder of Cipla Ltd Dr Y K Hamied and Special recognition award to Drugs Controller General of India Dr V G Somani.
Dr Debabrata Dash of Banaras Hindu University, Varanasi will be given the OPPI Scientist of the Year award. Dr Rituparna Sinha Roy of the Indian Institutes of Science Education and Research (IISER), Kolkata, will receive the OPPI Woman Scientist of the Year. The OPPI Young Scientist of the Year award will be given to Dr Arun Kumar Shukla, Indian Institute of Technology, Kanpur.
The summit will host five panel discussions on ‘India’s Healthcare Transformation journey’ and the role of Finance, Technology, Trust and Quality in Healthcare and Pharmaceuticals sectors with Indian and global experts from government, regulators, industry, NGOs and the academia.
In a special session on COVID19 Vaccine Updates, Jaak Peeters, Johnson & Johnson Special Envoy for COVID-19 Vaccine and Narender Mantena, Head of Global Strategy & CEO, Specialty Generic Injectables & Synthetic Biology, Biological E Ltd will interact with Sarthak Ranade, Managing Director of Janssen India.
On the 2020 Annual Summit, OPPI president Sharad Tyagi said, “OPPI is glad to bring such high voltage discussions on India’s Healthcare transformation during these testing times. Healthcare and Pharmaceutical industry have worked hand in hand with the government and the regulators in the last 10 months to ensure that the COVID virus is controlled in our country with all our might. The summit will pave way to take these collaborations and partnerships to the next level.”
OPPI Director General KG Ananthakrishnan said, “the summit is taking place at a time when the whole world is undergoing a rapid change in healthcare forced by the COVID19 virus. Therefore, the two-day summit has been carefully crafted keeping in mind the advances in digital healthcare technologies, the interest of patients and the healthy citizens, and the need to evolve industry friendly policies to safeguard the patients and the industry.
